Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Wesfarmers (WES.AX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (A$) Price Target (A$) Rating
2022-02-1654.9259.00Neutral
2022-02-1850.4154.00Neutral
2022-05-2346.1856.00Buy
2022-08-2647.9555.00Buy
2022-11-2948.3656.00Buy
2023-02-1651.3255.50Buy
2023-08-2651.0057.00Buy
2023-10-1052.1756.50Buy
2023-10-3150.5256.00Buy
2023-12-1354.3855.00Neutral
2024-02-1561.9161.00Neutral
2024-05-0368.3166.00Neutral
2024-08-3072.6066.00Sell
2025-01-2172.8869.00Sell
2025-02-0574.7076.00Neutral
2025-02-2176.1278.00Neutral

Disclosures

  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.